In November 2014, the Oxford-Harrington Scholarship Programme was launched to support physician-scientists at the University of Oxford, to translate discovery science into medicines that improve human health. This collaboration between the University of Oxford and Harrington Discovery Institute leveraged their combined expertise and resources to advance drug discovery projects.
This program was designed to provide consultancy-based support to researchers working on novel drug discovery research problems that have demonstrable potential to become new therapies, but may not be far enough along in the drug development path to receive support from financial investors.
This program was replaced in 2019 by the Harrington UK Rare Disease program.